<DOC>
	<DOCNO>NCT00542529</DOCNO>
	<brief_summary>This study randomize , placebo-controlled , dose-escalation , single-center study evaluate two different dos Imprime PGG , 7 different dose regime . A total 66 subject enrol 2 cohort , within cohort , randomize 1 7 treatment group receive Imprime PGG placebo vary dose regimen granulocyte-colony stimulating factor ( G-CSF ) .</brief_summary>
	<brief_title>Phase I/II , Randomized , Double-Blind , Study Progenitor Cell Mobilizing Effects Imprime PGG™ Injection Administered Varied Dosing Regimens With G-CSF Versus G-CSF Alone</brief_title>
	<detailed_description />
	<criteria>1 . Be age 18 45 , inclusive 2 . Have body weight 45 kg 125 kg , inclusive , body mass index less equal 30 kg/m2 3 . Be healthy base medical history , physical examination , electrocardiogram ( ECG ) , clinical laboratory test result 4 . If female , nonpregnant nonnursing . For either gender , subject must either sexually inactive ( 14 day prior first dose study drug throughout study ) practice least two method birth control follow list acceptable form contraception : 1 . Surgically sterile subject partner ( bilateral tubal ligation , hysterectomy , bilateral oophorectomy vasectomy perform least 6 month prior first dose study drug ) 2 . Intrauterine device ( IUD ) place least 3 month 3 . Barrier method ( condom , diaphragm ) spermicide time subject/partner 's last menstrual period throughout study 4 . Hormonal contraceptive least 3 month prior first dose study drug 5 . Has read , understood sign IRBapproved informed consent form ( ICF ) 1 . Has know hypersensitivity baker 's yeast , GCSF , E.coliderived proteins , active yeast infection 2 . Has clinical condition , opinion investigator , warrant exclusion study scientific , procedural , safety perspective 3 . Has history tobacco use within 90 day last day screen ( Day 1 ) know suspect abuser alcohol drugs/substances abuse 4 . Has positive hepatitis B , hepatitis C , human immunodeficiency virus ( HIV ) test conduct part screen 5 . Except otherwise indicate , take prescription medication within 30 day last day screen ( Day 1 ) overthecounter medication , herbal preparation , vitamin within 7 day last day screen ( Day 1 ) 6 . Has participate investigational drug study within 30 day five halflives ( whichever longer ) last day screen ( Day 1 ) , receive GCSF within 30 day last day screening , ever participate study Imprime PGG Betafectin® 7 . Has donate lose unit blood within 30 day last day screen ( Day 1 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Healthy Subjects</keyword>
</DOC>